Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Amortizatization of Intangibles (2019 - 2025)

Intellia Therapeutics (NTLA) has disclosed Amortizatization of Intangibles for 7 consecutive years, with $3.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles changed N/A to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.9 million, a N/A change, with the full-year FY2025 number at $5.9 million, changed N/A from a year prior.
  • Amortizatization of Intangibles was $3.3 million for Q4 2025 at Intellia Therapeutics, up from -$1.4 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $7.9 million in Q3 2023 to a low of -$9.9 million in Q3 2024.
  • A 5-year average of $1.1 million and a median of $1.2 million in 2022 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 2779.45% in 2021, then soared 1061.53% in 2023.
  • Intellia Therapeutics' Amortizatization of Intangibles stood at -$2.6 million in 2021, then skyrocketed by 147.42% to $1.2 million in 2022, then skyrocketed by 404.96% to $6.3 million in 2023, then plummeted by 257.51% to -$9.9 million in 2024, then surged by 133.59% to $3.3 million in 2025.
  • Per Business Quant, the three most recent readings for NTLA's Amortizatization of Intangibles are $3.3 million (Q4 2025), -$1.4 million (Q3 2025), and $1.7 million (Q2 2025).